“…Artemisinin and its derivatives rapidly clear parasitaemia within three days (48 hr) of dose treatments, and other antimalarial group drugs clear the remaining parasites by their different modes of therapeutic action (Fairhurst & Dondorp, 2016;Sugiarto, Davis & Salman, 2017). For the treatment of uncomplicated malaria, five combinations are approved by the WHO as artemether-lumefantrine (AL) (marketed as Coartem-Dispersible; Wells et al, 2015), artesunateamodiaquine (marketed as ASAQ Winthrop; Wells et al, 2015), artesunate-mefloquine (marketed as ASMQ) (Wells et al, 2015), artesunate-sulfadoxine-pyrimethamine or artesunate-pyronaridine (marketed as Pyramax) (Achieng et al, 2017;Phyo & Seidlein, 2017;Wells et al, 2015), and dihydroartemisinin-piperaquine (marketed as Eurartesim) (Ashley, Dhorda, Fairhurst, Amaratunga & Lim, 2014;Gregson & Plowe, 2005;Jana & Paliwal, 2007;Satish, Puttur, Coutinho, Amber & Nandan, 2018;Thu et al, 2017;Wells et al, 2015;World Health Organization, 2017).…”